BioGeneration Ventures Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Professionals
  • 8

Professionals
  • Investments
  • 75

  • Portfolio
  • 31

  • Exits
  • 20

Exits

BioGeneration Ventures General Information

Description

Founded in 2006, BioGeneration Ventures is a venture capital firm based in Naarden, Netherlands. The firm invests in the life sciences, medical, and healthcare sectors.

Contact Information

Year Founded
2006
Investor Status
Actively Seeking New Investments
Trade Association
Dutch Venture Capital Association (NVP)
Primary Investor Type
Venture Capital
Other Investor Types
Asset Manager
Primary Office
  • Gooimeer 2-35
  • 1411 DC Naarden
  • Netherlands
+31 035 000 0000

BioGeneration Ventures Investments (75)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Catalym 22-Nov-2022 Later Stage VC 000.00 Drug Discovery Clinical Trials - Phase 2 00000 00000000
00000000000 000000 17-Nov-2022 0000 00000 0000 Pharmaceuticals Generating Revenue 0000 000000000 00.0
000000000000 00000 01-Nov-2022 00000 00000 Drug Discovery Clinical Trials - Phase 3
00000000000 22-Sep-2022 0000 00000 Therapeutic Devices Product In Beta Test
00000 000000000000 16-May-2022 0000 00000 Drug Discovery Startup 000000 0000000000 00.0
000000 0000000 10-Mar-2022 00000 00000 000.00 Biotechnology Generating Revenue 000000 000 00000
0000000000 0000000 23-Feb-2022 0000 00000 00.000 Biotechnology Generating Revenue 0000000 00000 00.0
000000 18-Feb-2022 00000 00000 000.00 Drug Discovery Pre-Clinical Trials
River BioMedics 20-Jan-2022 Seed Round 00.000 Drug Discovery Generating Revenue 000000 0000000000 00.0
NorthSea Therapeutics 17-Dec-2021 Later Stage VC 0000 Drug Discovery Clinical Trials - Phase 2
You’re viewing 10 of 75 investments. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BioGeneration Ventures Exits (20)

Company Name Exit Date Exit Type Exit Size
Bala Therapeutics 13-Jan-2022 Out of Business
0000 000000000000 13-Jan-2022 000 00 00000000
000000 00000000000 31-Dec-2021 000 00 00000000
00000 000000000000 31-Dec-2021 000 00 00000000
000000 00000000000 17-Dec-2018 000000000000000000 00000
000-000000 01-Jan-2018 0000000000: 000000
0000000 0000000000 01-Jan-2018 0000000000: 000000
0000000000 18-Oct-2017 000000000000000000
Mucosis 27-Jun-2017 Bankruptcy: Liquidation
Medisse 01-Apr-2016 Out of Business
You’re viewing 10 of 20 exits. Get the full list »

BioGeneration Ventures Fund Performance

Fund Name Vintage Size Dry Powder DPI RVPI TVPI IRR

This information is available in the PitchBook Platform. To explore BioGeneration Ventures‘s full profile, request access.

Request a free trial

BioGeneration Ventures Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

BioGeneration Ventures Team (24)

Name Title Deals Funds Boards Office
Edward Van Wezel Founder & Managing Partner 00 0 00 Naarden, Netherlands
Oskar Slotboom General Partner 00 0 0 Naarden, Netherlands
Arnoud Dijkstra Ph.D Venture Partner Naarden, Netherlands
Elena Ritsou Ph.D Venture Partner Naarden, Netherlands
Wouter Verhoeven Venture Partner Naarden, Netherlands
You’re viewing 5 of 24 team members. Get the full list »

BioGeneration Ventures Co-Investors (76)

Name With Exits Lead Partner Series Industry
Forbion 6 0 Series chart Industry bar
OrbiMed 0 0 0 Series chart Industry bar
i2020 Accelerator 0 0 0 Series chart Industry bar
Inkef 0 0 Series chart Industry bar
Ysios Capital 0 0 Series chart Industry bar
You’re viewing 5 of 76 co-investors. Get the full list »